Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Stereotactic body radiotherapy as primary treatment for elderly patients with medically-inoperable head-and-neck cancer

Vargo, JA and Ferris, RL and Clump, DA and Heron, DE (2014) Stereotactic body radiotherapy as primary treatment for elderly patients with medically-inoperable head-and-neck cancer. Frontiers in Oncology, 4 JUL.

[img]
Preview
PDF
Published Version
Available under License : See the attached license file.

Download (920kB)
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)

Abstract

Purpose: With a growing elderly population, elderly patients with head-and-neck cancers represent an increasing challenge with limited prospective data to guide management. The complex interplay between advanced age, associated comorbidities, and conventional local therapies such as surgery and external beam radiotherapy ± chemotherapy, can significantly impact elderly patients' quality-of-life (QOL). SBRT is a well-established curative strategy for medicalinoperable. early-stage lung cancers even in elderly populations; however there is limited data examining SBRT as primary therapy in head-and-neck cancer. Material/Methods: Twelve patients with medically-inoperable head-and-neck cancer treated with SBRT ± cetuximab from 2002 through 2013 were retrospectively reviewed. SBRT consisted of primarily 44Gy in 5 fractions delivered on alternating days over 1-2 weeks. Concurrent cetuximab was administer at a dose of 400mg/m2 on day -7 followed by 250mg/m2 on day 0 and +7 in n=3 (25%). Patient reported quality-of-life (PRQoL) was prospectively recorded using the previously-validated University-of-Washington Quality-of-Life Revised (UW-QoL-R). Results: Median clinical follow-up was 6-months (range: 0.5 - 29 months). The 1-year actuarial local progression-free survival, distant progression-free survival,progression-free survival, and overall survival for definitively treated patients were 69%, 100%, 69% and 64%, respectively. One patient (8%) experienced acute grade 3 dysphagia and one patient (8%) experienced late grade 3 mucositis; there were no grade 4-5 toxicities. Prospective collection of patient report quality-of-life as assessed by UW-QoL-R was preserved across domains. Conclusion: SBRT shows encouraging survival and relatively low toxicity in elderly patients with unresectable head-and-neck cancer; which may provide an aggressive potentially curative local therapy while maintaining quality-of-life. © 2014 Vargo, Ferris, Clump and Heron.


Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: Article
Status: Published
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Vargo, JA
Ferris, RLrlf1@pitt.eduRLF1
Clump, DAdac158@pitt.eduDAC158
Heron, DEdeh5@pitt.eduDEH5
Centers: Other Centers, Institutes, Offices, or Units > Hillman Cancer Center
Date: 1 January 2014
Date Type: Publication
Journal or Publication Title: Frontiers in Oncology
Volume: 4 JUL
DOI or Unique Handle: 10.3389/fonc.2014.00214
Schools and Programs: School of Medicine > Otolaryngology
Refereed: Yes
Date Deposited: 01 Jun 2015 21:37
Last Modified: 02 Feb 2019 23:55
URI: http://d-scholarship.pitt.edu/id/eprint/24756

Metrics

Monthly Views for the past 3 years

Plum Analytics

Altmetric.com


Actions (login required)

View Item View Item